Clozapine in the treatment of refractory schizophrenia: Canadian policies and clinical guidelines

Canadian Journal of Psychiatry

Volumn 37, Issue 7, 1992, Pages 482-496

  Collins, E J ^a   Lalonde, P ^a   Jones, B D ^a   Addington, D ^a   MacCrimmon, D J ^a   MacEwan, G W ^a   Teehan, M D ^a  

^a Mental Health Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARBAMAZEPINE; CIMETIDINE; CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; PROPYLTHIOURACIL; SULFONAMIDE; THIAZIDE DIURETIC AGENT;

ADULT; AGRANULOCYTOSIS; DRUG SAFETY; EXTRAPYRAMIDAL SYNDROME; GASTROINTESTINAL SYMPTOM; HUMAN; NEUROTOXICITY; POLICY; REVIEW; SCHIZOPHRENIA;

EID: 0026463930     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379203700704     Document Type: Review

References (0)